Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ABROCITINIB (CIBINQO) and IBRUTINIB (Imbruvica) — clinical data, side effects, and patient experiences.
CIBINQO, Cibinqo · JAK Inhibitor
How it works
12.1 Mechanism of Action CIBINQO is a Janus kinase (JAK) inhibitor. Abrocitinib reversibly inhibits JAK1 by blocking the adenosine triphosphate (ATP) binding site. In a cell-free i...
Approved for
Imbruvica · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, ...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 24 Reddit discussions
ABROCITINIB
47%
positive
15 threads
IBRUTINIB
56%
positive
9 threads
% of discussions mentioning each side effect
15 Reddit threads analysed for ABROCITINIB
Overall Sentiment
Mixed
Comparison Threads
2
Avg Post Score
8 upvotes
Most discussed side effects in community
Threads directly comparing ABROCITINIB to other medications
Would someone please cross post to r/dyshidrosis. (they won't let me post because I am a professional researcher in the field). # Traditional Hand Eczema Treatments May Face Obsolescence Ted Bosworth December 18, 2024 [2]()[55]()Add to Email Alerts NEW YORK, NY — For immediate control of a hand ecz
# Traditional Hand Eczema Treatments May Face Obsolescence Ted Bosworth December 18, 2024 [2]()[55]()Add to Email Alerts NEW YORK, NY — For immediate control of a hand eczema flare, the old soak and smear approach with moisturizers or corticosteroids might live on, but they are moving to the back of
Recently started taking a new drug through a clinical trial called Abrocitinib (Made by Pfizer), it is an oral tablet once a day and from what my doctors have said it is comparable and even slightly more effective for people than Dupixent. I wanted to share my results, I have had severe eczema for 7
I've given a few updates on the trial I'm in for Abrocitinib over the past couple of years - thought I'd round it out now the trial is coming to an end. I think I last posted around the 18 month mark and said I felt the effects were wearing off and some mild eczema had returned. I'm happy to say th
I've had full body eczema since about 18 years old. I can't really remember what my skin was like before then. Managing my eczema has been such a big part of my adult life. But after 2 months on dupixent I feel like my skin has never been as smooth.. or as oily! It's honestly taking my brain a whil
Quick rant here! Because It’s getting annoying and frustrating that they always hype up the new drugs for eczema sufferers for example, the JAK inhibitors, and I’m so happy to read the results but they never want to discuss the adverse side effects. They always want to say it’s mild and that they’re
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
9 Reddit threads analysed for IBRUTINIB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
48 upvotes
Most discussed side effects in community
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hi everyone. I’m looking for insight from others with CLL experience. My dad has CLL with 96% involvement in his bone marrow per recent biopsy. His platelets are low, and over the past two weeks his anemia has worsened very very quickly. Recent timeline: Hospitalized with hemoglobin \~7.5 and fever
To Those Who Wish to learn, I feel like I may be giving away a secret.... but... here it goes... Earlier today I had a [twitter conversation](https://twitter.com/sentivcapital/status/1663230898702106634) about AI in regards to potential for future impact on stocks. I received a lot of DMs and to be
I’ve been pretty successful in a media career but now, at 43, 3 years post my diagnosis with my cancer under control (no cure... a rare lymphoma/on ibrutinib forever) two kids 7 and 4 at home and the sole breadwinner for the family, I’m so disenchanted. I finally feel great health wise... back to m
I was researching to find out * Examples of cancer drugs in the past that came to market later where treatments already existed, but ended up being commercially successful - * What were the characteristics of these late entrants that led to their success and does Cosibelimab have some of these char
**Is progression a meaningful outcome measure for a patient with indolent lymphoma** **If I don't feel anything (i.e. asymptomatic) and can live for decades with my lymphoma should I even worry about the fact that I have some enlarged lymph nodes or abnormalities of my lab work ???** I had a dis
Apparently a patient had been administering the medication this way... It's on the ISMP do not crush list. I called the manufacturer (Pharmacyclics) and they had no data on administering through any enteral feeding tubes, so they recommended not to give the medication in this manner. I can't find an
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
ABROCITINIB is a JAK Inhibitor, while IBRUTINIB belongs to the Targeted Cancer Therapy class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
ABROCITINIB carries 4 FDA warnings. IBRUTINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.